What is ACTU stock price today?

View the current ACTU stock price, daily change, and comprehensive market data on our real-time stock dashboard.

How to analyze Actuate Therapeutics Inc stock?

Analyze Actuate Therapeutics Inc stock using key metrics like P/E ratio, EPS, dividend yield, market cap, revenue growth, and price performance charts available on our dashboard.

What are ACTU key financial metrics?

Key ACTU financial metrics include current stock price, P/E ratio, EPS, dividend yield, market capitalization, 52-week high/low, daily trading volume, and financial health indicators.

ACTU Stock Analysis

Actuate Therapeutics Inc - Real-time stock metrics, market data, and comprehensive analysis

Member SIPC.

Low Commissions

Learn More

Actuate Therapeutics Inc

Actuate is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers. Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy including EMT, NF-kB-mediated resistance and several DDR pathways. Elraglusib also acts as a mediator of anti-tumor immunity through the inhibition of NF-kB in immune cells and regulates multiple immune checkpoints and immune cell function.

Market Data

Current Price

$2.00

+$0.18 (9.89%)

Market Cap

-

Total Company Value

Day Range

$1.89 - $2.29

Session Volume

9K

Last session total

Valuation Metrics

P/E Ratio

-

Price ÷ Earnings

EPS (Basic)

-

Earnings Per Share

Price-to-Book

-

Market Value ÷ Book Value

Financial Health

Revenue (TTM)

-

Trailing 12 Months

Net Income (TTM)

-

Profit After Tax

Gross Margin

-

Revenue Efficiency

Returns & Dividends

Dividend Yield

-

Annual Dividend ÷ Price

Annual Dividend

-

Per Share

Payout Ratio

-

Dividend ÷ EPS

Price Performance

Price Chart

1D 5D 1M 3M 6M 1Y 5Y 10Y

All times are in Eastern Time (ET)

Recent News

No news available

Data Source: Financial data is sourced from SEC filings via Tiingo and may be delayed. Market Status: CLOSED - Showing latest available data. (Last updated: 3:23 PM)
Logos provided by Logo.dev